China IVIG Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 IVIG Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China IVIG Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China IVIG Overall Market Size
2.1 China IVIG Market Size: 2021 VS 2027
2.2 China IVIG Revenue, Prospects & Forecasts: 2016-2027
2.3 China IVIG Sales: 2016-2027
3 Company Landscape
3.1 Top IVIG Players in China Market
3.2 Top China IVIG Companies Ranked by Revenue
3.3 China IVIG Revenue by Companies
3.4 China IVIG Sales by Companies
3.5 China IVIG Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 IVIG Companies in China Market, by Revenue in 2020
3.7 Manufacturers IVIG Product Type
3.8 Tier 1, Tier 2 and Tier 3 IVIG Players in China Market
3.8.1 List of Tier 1 IVIG Companies in China
3.8.2 List of Tier 2 and Tier 3 IVIG Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China IVIG Market Size Markets, 2021 & 2027
4.1.2 Injection IVIG
4.1.3 Lyophilized Powder IVIG
4.2 By Type - China IVIG Revenue & Forecasts
4.2.1 By Type - China IVIG Revenue, 2016-2021
4.2.2 By Type - China IVIG Revenue, 2022-2027
4.2.3 By Type - China IVIG Revenue Market Share, 2016-2027
4.3 By Type - China IVIG Sales & Forecasts
4.3.1 By Type - China IVIG Sales, 2016-2021
4.3.2 By Type - China IVIG Sales, 2022-2027
4.3.3 By Type - China IVIG Sales Market Share, 2016-2027
4.4 By Type - China IVIG Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China IVIG Market Size, 2021 & 2027
5.1.2 Multiple Sclerosis(MS)
5.1.3 Myasthenia Gravis(MG)
5.1.4 Multifocal Motor Neuropathy(MMN)
5.1.5 Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
5.1.6 Dermatomyositis
5.1.7 Polymyositis
5.2 By Application - China IVIG Revenue & Forecasts
5.2.1 By Application - China IVIG Revenue, 2016-2021
5.2.2 By Application - China IVIG Revenue, 2022-2027
5.2.3 By Application - China IVIG Revenue Market Share, 2016-2027
5.3 By Application - China IVIG Sales & Forecasts
5.3.1 By Application - China IVIG Sales, 2016-2021
5.3.2 By Application - China IVIG Sales, 2022-2027
5.3.3 By Application - China IVIG Sales Market Share, 2016-2027
5.4 By Application - China IVIG Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Green Cross
6.1.1 Green Cross Corporation Information
6.1.2 Green Cross Overview
6.1.3 Green Cross IVIG Sales and Revenue in China Market (2016-2021)
6.1.4 Green Cross IVIG Product Description
6.1.5 Green Cross Recent Developments
6.2 BSV
6.2.1 BSV Corporation Information
6.2.2 BSV Overview
6.2.3 BSV IVIG Sales and Revenue in China Market (2016-2021)
6.2.4 BSV IVIG Product Description
6.2.5 BSV Recent Developments
6.3 Hualan Bio
6.3.1 Hualan Bio Corporation Information
6.3.2 Hualan Bio Overview
6.3.3 Hualan Bio IVIG Sales and Revenue in China Market (2016-2021)
6.3.4 Hualan Bio IVIG Product Description
6.3.5 Hualan Bio Recent Developments
6.4 RAAS
6.4.1 RAAS Corporation Information
6.4.2 RAAS Overview
6.4.3 RAAS IVIG Sales and Revenue in China Market (2016-2021)
6.4.4 RAAS IVIG Product Description
6.4.5 RAAS Recent Developments
6.5 YUAN DA SHUYANG
6.5.1 YUAN DA SHUYANG Corporation Information
6.5.2 YUAN DA SHUYANG Overview
6.5.3 YUAN DA SHUYANG IVIG Sales and Revenue in China Market (2016-2021)
6.5.4 YUAN DA SHUYANG IVIG Product Description
6.5.5 YUAN DA SHUYANG Recent Developments
6.6 Kangbao Bio
6.6.1 Kangbao Bio Corporation Information
6.6.2 Kangbao Bio Overview
6.6.3 Kangbao Bio IVIG Sales and Revenue in China Market (2016-2021)
6.6.4 Kangbao Bio IVIG Product Description
6.6.5 Kangbao Bio Recent Developments
6.7 Tiantan Bio
6.7.1 Tiantan Bio Corporation Information
6.7.2 Tiantan Bio Overview
6.7.3 Tiantan Bio IVIG Sales and Revenue in China Market (2016-2021)
6.7.4 Tiantan Bio IVIG Product Description
6.7.5 Tiantan Bio Recent Developments
6.8 Taibang Bio
6.8.1 Taibang Bio Corporation Information
6.8.2 Taibang Bio Overview
6.8.3 Taibang Bio IVIG Sales and Revenue in China Market (2016-2021)
6.8.4 Taibang Bio IVIG Product Description
6.8.5 Taibang Bio Recent Developments
6.9 Weiguang Bio
6.9.1 Weiguang Bio Corporation Information
6.9.2 Weiguang Bio Overview
6.9.3 Weiguang Bio IVIG Sales and Revenue in China Market (2016-2021)
6.9.4 Weiguang Bio IVIG Product Description
6.9.5 Weiguang Bio Recent Developments
6.10 SIBP
6.10.1 SIBP Corporation Information
6.10.2 SIBP Overview
6.10.3 SIBP IVIG Sales and Revenue in China Market (2016-2021)
6.10.4 SIBP IVIG Product Description
6.10.5 SIBP Recent Developments
6.11 TONROL
6.11.1 TONROL Corporation Information
6.11.2 TONROL Overview
6.11.3 TONROL IVIG Sales and Revenue in China Market (2016-2021)
6.11.4 TONROL IVIG Product Description
6.11.5 TONROL Recent Developments
6.12 RUIDE Bio
6.12.1 RUIDE Bio Corporation Information
6.12.2 RUIDE Bio Overview
6.12.3 RUIDE Bio IVIG Sales and Revenue in China Market (2016-2021)
6.12.4 RUIDE Bio IVIG Product Description
6.12.5 RUIDE Bio Recent Developments
6.13 BOYA Bio
6.13.1 BOYA Bio Corporation Information
6.13.2 BOYA Bio Overview
6.13.3 BOYA Bio IVIG Sales and Revenue in China Market (2016-2021)
6.13.4 BOYA Bio IVIG Product Description
6.13.5 BOYA Bio Recent Developments
6.14 RUIDE Bio
6.14.1 RUIDE Bio Corporation Information
6.14.2 RUIDE Bio Overview
6.14.3 RUIDE Bio IVIG Sales and Revenue in China Market (2016-2021)
6.14.4 RUIDE Bio IVIG Product Description
6.14.5 RUIDE Bio Recent Developments
6.15 Xinxing Medicine
6.15.1 Xinxing Medicine Corporation Information
6.15.2 Xinxing Medicine Overview
6.15.3 Xinxing Medicine IVIG Sales and Revenue in China Market (2016-2021)
6.15.4 Xinxing Medicine IVIG Product Description
6.15.5 Xinxing Medicine Recent Developments
6.16 Weilun Bio
6.16.1 Weilun Bio Corporation Information
6.16.2 Weilun Bio Overview
6.16.3 Weilun Bio IVIG Sales and Revenue in China Market (2016-2021)
6.16.4 Weilun Bio IVIG Product Description
6.16.5 Weilun Bio Recent Developments
6.17 WIBP
6.17.1 WIBP Corporation Information
6.17.2 WIBP Overview
6.17.3 WIBP IVIG Sales and Revenue in China Market (2016-2021)
6.17.4 WIBP IVIG Product Description
6.17.5 WIBP Recent Developments
7 China IVIG Production Capacity, Analysis
7.1 China IVIG Production Capacity, 2016-2027
7.2 IVIG Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 IVIG Supply Chain Analysis
9.1 IVIG Industry Value Chain
9.2 IVIG Upstream Market
9.3 IVIG Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 IVIG Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of IVIG in China Market
Table 2. Top IVIG Players in China Market, Ranking by Revenue (2019)
Table 3. China IVIG Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China IVIG Revenue Share by Companies, 2016-2021
Table 5. China IVIG Sales by Companies, (K Pcs), 2016-2021
Table 6. China IVIG Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers IVIG Price (2016-2021) & (USD/Pcs)
Table 8. Manufacturers IVIG Product Type
Table 9. List of Tier 1 IVIG Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 IVIG Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Injection IVIG
Table 12. Major Manufacturers of Lyophilized Powder IVIG
Table 13. By Type - China IVIG Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China IVIG Revenue (US$, Mn), 2016-2021
Table 15. By Type - China IVIG Revenue (US$, Mn), 2022-2027
Table 16. By Type - China IVIG Sales (K Pcs), 2016-2021
Table 17. By Type - China IVIG Sales (K Pcs), 2022-2027
Table 18. By Application - China IVIG Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China IVIG Revenue (US$, Mn), 2016-2021
Table 20. By Application - China IVIG Revenue (US$, Mn), 2022-2027
Table 21. By Application - China IVIG Sales (K Pcs), 2016-2021
Table 22. By Application - China IVIG Sales (K Pcs), 2022-2027
Table 23. Green Cross Corporation Information
Table 24. Green Cross Description and Major Businesses
Table 25. Green Cross IVIG Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 26. Green Cross IVIG Product
Table 27. Green Cross Recent Developments
Table 28. BSV Corporation Information
Table 29. BSV Description and Major Businesses
Table 30. BSV IVIG Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 31. BSV IVIG Product
Table 32. BSV Recent Developments
Table 33. Hualan Bio Corporation Information
Table 34. Hualan Bio Description and Major Businesses
Table 35. Hualan Bio IVIG Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 36. Hualan Bio IVIG Product
Table 37. Hualan Bio Recent Developments
Table 38. RAAS Corporation Information
Table 39. RAAS Description and Major Businesses
Table 40. RAAS IVIG Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 41. RAAS IVIG Product
Table 42. RAAS Recent Developments
Table 43. YUAN DA SHUYANG Corporation Information
Table 44. YUAN DA SHUYANG Description and Major Businesses
Table 45. YUAN DA SHUYANG IVIG Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 46. YUAN DA SHUYANG IVIG Product
Table 47. YUAN DA SHUYANG Recent Developments
Table 48. Kangbao Bio Corporation Information
Table 49. Kangbao Bio Description and Major Businesses
Table 50. Kangbao Bio IVIG Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 51. Kangbao Bio IVIG Product
Table 52. Kangbao Bio Recent Developments
Table 53. Tiantan Bio Corporation Information
Table 54. Tiantan Bio Description and Major Businesses
Table 55. Tiantan Bio IVIG Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 56. Tiantan Bio IVIG Product
Table 57. Tiantan Bio Recent Developments
Table 58. Taibang Bio Corporation Information
Table 59. Taibang Bio Description and Major Businesses
Table 60. Taibang Bio IVIG Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 61. Taibang Bio IVIG Product
Table 62. Taibang Bio Recent Developments
Table 63. Weiguang Bio Corporation Information
Table 64. Weiguang Bio Description and Major Businesses
Table 65. Weiguang Bio IVIG Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 66. Weiguang Bio IVIG Product
Table 67. Weiguang Bio Recent Developments
Table 68. SIBP Corporation Information
Table 69. SIBP Description and Major Businesses
Table 70. SIBP IVIG Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 71. SIBP IVIG Product
Table 72. SIBP Recent Developments
Table 73. TONROL Corporation Information
Table 74. TONROL Description and Major Businesses
Table 75. TONROL IVIG Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 76. TONROL IVIG Product
Table 77. TONROL Recent Developments
Table 78. RUIDE Bio Corporation Information
Table 79. RUIDE Bio Description and Major Businesses
Table 80. RUIDE Bio IVIG Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 81. RUIDE Bio IVIG Product
Table 82. RUIDE Bio Recent Developments
Table 83. BOYA Bio Corporation Information
Table 84. BOYA Bio Description and Major Businesses
Table 85. BOYA Bio IVIG Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 86. BOYA Bio IVIG Product
Table 87. BOYA Bio Recent Developments
Table 88. RUIDE Bio Corporation Information
Table 89. RUIDE Bio Description and Major Businesses
Table 90. RUIDE Bio IVIG Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 91. RUIDE Bio IVIG Product
Table 92. RUIDE Bio Recent Developments
Table 93. Xinxing Medicine Corporation Information
Table 94. Xinxing Medicine Description and Major Businesses
Table 95. Xinxing Medicine IVIG Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 96. Xinxing Medicine IVIG Product
Table 97. Xinxing Medicine Recent Developments
Table 98. Weilun Bio Corporation Information
Table 99. Weilun Bio Description and Major Businesses
Table 100. Weilun Bio IVIG Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 101. Weilun Bio IVIG Product
Table 102. Weilun Bio Recent Developments
Table 103. WIBP Corporation Information
Table 104. WIBP Description and Major Businesses
Table 105. WIBP IVIG Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 106. WIBP IVIG Product
Table 107. WIBP Recent Developments
Table 108. IVIG Production Capacity (K Pcs) of Key Manufacturers in China Market, 2019-2021 (K Pcs)
Table 109. China IVIG Capacity Market Share of Key Manufacturers, 2019-2021
Table 110. IVIG Market Opportunities & Trends in China Market
Table 111. IVIG Market Drivers in China Market
Table 112. IVIG Market Restraints in China Market
Table 113. IVIG Raw Materials
Table 114. IVIG Raw Materials Suppliers in China Market
Table 115. Typical IVIG Downstream
Table 116. IVIG Downstream Clients in China Market
Table 117. IVIG Distributors and Sales Agents in China Market
List of FiguresFigure 1. IVIG Product Picture
Figure 2. IVIG Segment by Type
Figure 3. IVIG Segment by Application
Figure 4. China IVIG Market Overview: 2020
Figure 5. China IVIG Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China IVIG Revenue, 2016-2027 (US$, Mn)
Figure 7. IVIG Sales in China Market: 2016-2027 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by IVIG Revenue in 2020
Figure 9. Injection IVIG Product Picture
Figure 10. Lyophilized Powder IVIG Product Picture
Figure 11. By Type - China IVIG Sales Market Share, 2016-2027
Figure 12. By Type - China IVIG Revenue Market Share, 2016-2027
Figure 13. By Type - China IVIG Price (USD/Pcs), 2016-2027
Figure 14. Multiple Sclerosis(MS)
Figure 15. Myasthenia Gravis(MG)
Figure 16. Multifocal Motor Neuropathy(MMN)
Figure 17. Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
Figure 18. Dermatomyositis
Figure 19. By Application - China IVIG Sales Market Share, 2016-2027
Figure 20. By Application - China IVIG Revenue Market Share, 2016-2027
Figure 21. By Application - China IVIG Price (USD/Pcs), 2016-2027
Figure 22. Green Cross IVIG Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. BSV IVIG Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Hualan Bio IVIG Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. RAAS IVIG Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. YUAN DA SHUYANG IVIG Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Kangbao Bio IVIG Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Tiantan Bio IVIG Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Taibang Bio IVIG Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Weiguang Bio IVIG Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. SIBP IVIG Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. TONROL IVIG Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. RUIDE Bio IVIG Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. BOYA Bio IVIG Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. RUIDE Bio IVIG Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Xinxing Medicine IVIG Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. Weilun Bio IVIG Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. WIBP IVIG Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. China IVIG Production Capacity (K Pcs), 2016-2027
Figure 40. IVIG Industry Value Chain
Figure 41. Marketing Channels